Covington & Burling advised Insmed Incorporated on the transaction. Insmed Incorporated (Nasdaq: INSM) (“Insmed”) announced its entrance into an agreement to amend its $350 million term...
You must be a Standard 1 Year member to access this content.
Covington advised Eisai in the transaction. Eisai Co., Ltd. signed its agreement to transfer all future economic rights for elacestrant (generic name), approved for the treatment for...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Verastem, while Covington advised the underwriters in the offering. Verastem, Inc. announced its $85 million public offering of common stock and pre-funded warrants....
You must be a Standard 1 Year member to access this content.
Davis Polk advised Roivant Sciences Ltd. in the deal, while Covington represented the underwriter, Cantor Fitzgerald. Roivant Sciences Ltd. announced its debut SEC-registered offering of 30,000,000...
You must be a Standard 1 Year member to access this content.
Covington represented the underwriters on the deal. Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders,...
You must be a Standard 1 Year member to access this content.
